PharmaZell (Germany)

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

• Engineering 4.3×
• Environmental Science 2.5×
• Medicine 1.0×
• Biochemistry, Genetics and Molecular Biology 0.5×

By fractional works in all years, weighted toward what it does more of than the world: Public Health, Metabolic Syndrome, Obesity, Weight Loss, Inflammation, Cancer Therapy, Ketogenic Diet and Low-Carbohydrate Diet.

By volume in 2022–2025: Technology Assessment and Management, Safety Systems Engineering in Autonomy, Climate Change and Health Impacts and Urban Green Space and Health.

1. 1 Technology Assessment and Management Safety, Risk, Reliability and Quality 0 works
2. 2 Safety Systems Engineering in Autonomy Safety, Risk, Reliability and Quality 0 works
3. 3 Climate Change and Health Impacts Health, Toxicology and Mutagenesis 0 works
4. 4 Urban Green Space and Health Health, Toxicology and Mutagenesis 0 works
5. 5 Hemophilia Treatment and Research Hematology 0 works
6. 6 Platelet Disorders and Treatments Hematology 0 works
7. 7 Blood Coagulation and Thrombosis Mechanisms Hematology 0 works
8. 8 Chemotherapy-induced cardiotoxicity and mitigation Cardiology and Cardiovascular Medicine 0 works
9. 9 Venous Thromboembolism Diagnosis and Management Internal Medicine 0 works
10. 10 Protein purification and stability Molecular Biology 0 works

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

Output in 2018–2022 was 134% higher than in 2013–2017.